Performance analysis of X4 Pharmaceuticals (XFOR)
Annual Return
Over the past 3 years, XFOR has had an average annual return of -58.96%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, XFOR has had an average annual return of -53.40%, underperforming the benchmark SPY, which returned +12.73% annual.
Since Nov 16, 2017, XFOR has had an average annual return of -52.71%, underperforming the benchmark SPY, which returned +14.80% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.25% | -81.61% | -13.00% | -15.25% | -56.62% | -64.40% | -39.89% | -23.16% | -81.81% | -9.05% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.25% | -6.67% | +14.29% | +0% | +6.25% | +5.88% | -16.67% | -6.25% | |||||
| 2025 | -4.60% | -43.37% | -40.43% | -39.29% | -23.53% | -38.46% | -12.50% | +114.29% | -6.67% | +14.29% | -12.50% | +14.29% | -81.61% |
| 2024 | -7.00% | +23.66% | +43.48% | -19.39% | -9.77% | -42.50% | +37.68% | -12.63% | -3.61% | -26.25% | -20.34% | +85.11% | -13.00% |
| 2023 | +3.39% | -9.02% | -7.21% | +69.90% | +37.71% | -4.56% | -7.39% | -28.64% | -15.13% | -26.36% | -2.11% | +7.53% | -15.25% |
| 2022 | -9.93% | -27.35% | +16.85% | -26.44% | -5.88% | -20.14% | +32.17% | -22.37% | +72.03% | +11.33% | -21.24% | -33.71% | -56.62% |
| 2021 | +21.47% | +22.52% | -10.03% | -2.74% | +13.47% | -31.62% | -11.53% | -10.83% | +3.12% | -8.44% | -8.00% | -48.58% | -64.40% |
| 2020 | -22.42% | +28.70% | -6.38% | -6.90% | -8.32% | +9.17% | -20.42% | +12.94% | -19.20% | -15.17% | +14.96% | -2.55% | -39.89% |
| 2019 | +17.65% | +1.08% | +5.13% | +17.17% | -24.64% | -2.41% | -20.65% | +7.14% | -0.33% | -3.64% | -13.20% | +0.63% | -23.16% |
| 2018 | -1.18% | +16.97% | +55.19% | -12.49% | -14.03% | -78.92% | -30.58% | -9.13% | -29.23% | -17.32% | +190.37% | -40.35% | -81.81% |
| 2017 | +20.31% | -24.40% | -9.05% |
Drawdown analysis of X4 Pharmaceuticals (XFOR)
The maximum drawdown for the XFOR was -99.97%, occurring on Jul 10, 2025. This drawdown has not yet recovered.
The current XFOR drawdown is -99.92%.
Since Nov 16, 2017 XFOR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Mar 20, 2018 | 1836 | Jul 10, 2025 | Ongoing | Ongoing | Ongoing |
| -41.18% | Nov 28, 2017 | 11 | Dec 13, 2017 | 60 | Mar 13, 2018 | 71 |
| -6.41% | Mar 15, 2018 | 2 | Mar 19, 2018 | 1 | Mar 20, 2018 | 3 |
| -0.71% | Nov 16, 2017 | 1 | Nov 17, 2017 | 1 | Nov 20, 2017 | 2 |